NEW YORK – Point-of-care diagnostics firm DCN Dx announced on Monday that it has acquired microbiology testing firm Biomed Diagnostics.
Financial and other terms of the deal were not disclosed.
The acquisition will expand DCN Dx's "footprint in the point-of-use testing and sampling markets in both human and veterinary verticals," the firm said in a statement. White City, Oregon-based Biomed has previously developed tools for the surveillance of microorganisms that lead to infectious diseases in both humans and animals.
Its products include multiple sample collection and transportation tools as well as its InTray Colorex tests for microbes including methicillin-resistant Staphylococcus aureus and other resistant bacteria.